Accelerated Assessment Dry Spell Over As EMA Says Yes To Pharming’s Leniolisib

MAA Filing Is Planned In October

The EMA will fast-track its review of leniolisib • Source: Alamy

More from Review Pathways

More from Pathways & Standards